Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Gradientdose 5-amino-1-methylquinolinium treatment further enables investigation of doseresponse relationships between NNMT inhibition, NAD+ levels, and metabolic efficiency, improving mechanistic understanding and supporting targetbased research for metabolic diseases
By blocking NNMT, 5-Amino-1MQ drives several metabolic benefits: Boosts NAD Levels Inhibiting NNMT preserves more nicotinamide for NAD synthesis, leading to enhanced mitochondrial function, increased cellular energy output, and activation of sirtuins , the proteins involved in longevity and DNA repair
Side effects are very rare
AOD is a reconstructed form of the amino acids 176-191 and is a synthetic lipolytic domain, meaning it serves as a synthetic alternative for the natural growth hormone produced by your body
